New factsheet: Don’t miss the opportunity to extend your market exclusivity

Revenues from patented medicines are generally highest at the end of the protection period and therefore exclusivity is most important. Valea's latest factsheet explains how your company can plan for extended protection.

Why do life science companies need to know the SPC Regulation?

– For life science companies, it often takes a long time to bring products to market, making the effective patent term short. “SPC is a way to maximize protection time and therefore revenue,” says Joanna Applequist, European Patent Attorney at Valea.

Why is supplementary protection relevant now?

– SPCs are a constantly evolving area with many court cases and where the regulation will be amended shortly.

Read more in the factsheet here or at